Masimo Shareholders Approve Acquisition by Danaher
Masimo Corporation’s stockholders approved the acquisition by Danaher Corporation during a special virtual meeting held on May 1, 2026. The approval was for a merger agreement previously announced on February 16, 2026.
IRVINE, Calif.–(BUSINESS WIRE)–Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026 (the “Merger Agreement”), by and among Masimo, Danaher Corporation (“Danaher”) (NYSE: DHR) and Mobius Merger Sub, Inc. (the “Merger Sub”) at Masimo’s special meeting of stockholders held virtually on May 1, 2026 (